Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: a twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples